Clinical Cancer Drugs
Title:Meet Our Editor-in-Chief
Volume: 4
Author(s): Giulio Francia*
Affiliation:
- The University of Texas El Paso, TX,United States
Export Options
About this article
Cite this article as:
Francia Giulio*, Meet Our Editor-in-Chief, Clinical Cancer Drugs 2017; 4 (1) . https://dx.doi.org/10.2174/2212697X0401170526184110
DOI https://dx.doi.org/10.2174/2212697X0401170526184110 |
Print ISSN 2212-697X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-6988 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma
Current Gene Therapy Graphical Abstracts
Medicinal Chemistry Current Concepts on the Management of Chordoma
Current Drug Therapy BiOCl Pro-Catalyzed Synthesis of Benzoxazepines from 4'-Hydroxy-3', 5'- Dinitro Substituted Chalcones and Ortho-Aminophenol
Letters in Organic Chemistry Biological and Toxicological Evaluation of N-(4methyl-phenyl)-4-methylphthalimide on Bone Cancer in Mice
Anti-Cancer Agents in Medicinal Chemistry Silk Fibroin Based Drug Delivery Applications: Promises and Challenges
Current Drug Targets Achieving Detumescence of Ischemic Priapism with Intra-Cavernosal Injection of entanyl: An Unexpected Outcome of Miscommunication Error
Current Drug Safety Targeted Therapy of Multiple Myeloma: The Changing Paradigm at the Beginning of the New Millennium
Current Cancer Drug Targets Pyruvate Dehydrogenase Kinases in the Nervous System: Their Principal Functions in Neuronal-glial Metabolic Interaction and Neuro-metabolic Disorders
Current Neuropharmacology Thermal N-9 → N-7 Isomerization of (6-Substituted)-9-(2,3-Dihydro-5H-1,4-Benzodioxepin-3-yl)-9H-Purines in Solution: Mechanistic Aspects
Mini-Reviews in Organic Chemistry Smart Triggered Release in Controlled Drug Delivery
Current Drug Targets The Role of Dietary Approach in Irritable Bowel Syndrome
Current Medicinal Chemistry Protease-Activated Receptor 2: Are Common Functions in Glial and Immune Cells Linked to Inflammation-Related CNS Disorders?
Current Drug Targets Editorial
Recent Patents on Inflammation & Allergy Drug Discovery Metal Complexes with Aromatic N-Containing Ligands as Potential Agents in Cancer Treatment
Current Medicinal Chemistry - Anti-Cancer Agents PARP Inhibitors in Epithelial Ovarian Cancer
Recent Patents on Anti-Cancer Drug Discovery Nuclear Export Mediated Regulation of MicroRNAs: Potential Target for Drug Intervention
Current Drug Targets Inhibition of Angiogenesis as a Treatment Strategy for Neuroblastoma
Current Cancer Therapy Reviews Editorial [Hot Topic: Mini Hot Topic Title: Epigenetic Regulatory Mechanisms in Cancer, Development, and Evolution (Guest Editor: Douglas M. Ruden)]
Current Genomics Role of Microspheres in Drug Delivery-An Overview
Drug Delivery Letters